Datasets:

Suchinthana
/

support2-1

Dataset card Data Studio Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
3,101	56.698	0	female	0	6	484	COPD	COPD/CHF/Cirrhosis	2	13	$25-$50k	0	11,830	8,260.5078	7,625.27734	16	white	23.796875	14	0.860962	0.770996	1	0	0	no	null	null	no dnr	6	100	8.5	70	20	36.09375	null	3.099609	0.599976	1.799805	135	null	276	30	1,350	null	0	no(M2 and SIP pres)	0
3,102	55.34	1	male	0	16	49	CHF	COPD/CHF/Cirrhosis	4	11	under $11k	0	30,451	18,925.0469	17,940.8281	19.333328	white	18.898438	24	0.895996	0.825928	1	0	0	no	0.9	0.8	no dnr	16	62	6.799805	119	30	36.69531	240	null	null	0.799927	138	7.429688	312	25	1,775	0	0	<2 mo. follow-up	0
3,103	63.71799	0	female	0	4	482	COPD	COPD/CHF/Cirrhosis	1	8	null	0	6,560	3,361.3398	3,398.32812	11	white	16.097656	16	0.903931	0.837891	1	0	0	no	null	null	dnr after sadm	1	111	12	73	30	39.89844	166	3.599609	0.799927	2.099609	148	7.439453	141	56	1,660	null	null	no(M2 and SIP pres)	2.003906
3,104	70.54895	0	female	0	9	481	CHF	COPD/CHF/Cirrhosis	3	null	under $11k	0	14,419	7,425.9219	6,971.98828	14.5	white	19.597656	27	0.848999	0.751953	1	1	0	no	0.8	0.7	no dnr	9	48	16.898438	105	12	38.09375	59	3.799805	1.299805	2.199707	138	7.359375	183	71	5,380	0	1	no(M2 and SIP pres)	1
3,105	64.82996	0	male	0	8	477	CHF	COPD/CHF/Cirrhosis	3	null	null	0	16,287	9,790.8906	9,164.05469	20.5	white	17.296875	17	0.887939	0.812988	1	0	0	no	0.9	0.85	no dnr	8	63	3.5	110	16	38.59375	238	2	null	3.599609	133	7.389648	115	61	0	null	null	null	2.680176
3,106	67.797	1	male	1	10	10	MOSF w/Malig	ARF/MOSF	3	12	$25-$50k	0	99,187	60,955.6562	52,364	46	white	38.09375	58	0.202972	0.109985	16	0	0	yes	0.2	0.2	no dnr	10	76	14.798828	72	25	36.19531	356	3.799805	0.699951	2	137	7.089844	123	25	1,320	0	0	<2 mo. follow-up	0
3,107	78.836	1	female	1	17	17	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	140,610	73,381.8125	61,557.375	61.666657	white	48.296875	81	0.072998	0.026997	8	0	0	no	null	null	dnr after sadm	14	61	15.699219	79	30	38.19531	null	null	null	0.599976	136	null	132	6	1,550	null	0	<2 mo. follow-up	0
3,108	76.49597	0	male	0	3	473	COPD	COPD/CHF/Cirrhosis	2	10	null	0	3,392	1,745.9248	1,798.71973	null	white	22.5	30	0.712891	0.554932	1	0	0	yes	null	null	no dnr	3	72	11.699219	64	20	36.29688	null	3.599609	1.099854	0.899902	136	null	96	21	600	0	null	no(M2 and SIP pres)	0.494751
3,109	61.40198	1	male	1	3	3	MOSF w/Malig	ARF/MOSF	1	12	>$50k	0	54,985	30,964.4375	26,108.6094	30	white	51.796875	87	0.003	0	16	0	0	metastatic	null	null	dnr after sadm	2	104	10	60	12	36.29688	108.32812	null	null	1.299805	137	7.399414	97	40	1,400	null	null	<2 mo. follow-up	2.288086
3,110	64.51996	0	male	0	6	472	ARF/MOSF w/Sepsis	ARF/MOSF	2	10	$11-$25k	0	11,983	7,241.2617	6,769.12891	21	white	26.597656	48	0.769897	0.695923	1	0	0	no	0.99	0.95	no dnr	6	55	11	71	14	36.09375	600	3.699707	0.699951	6.799805	138	7.389648	197	55	390	0	0	no(M2 and SIP pres)	0
3,111	62.155	1	male	1	5	5	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	under $11k	0	32,587	19,519.9062	14,169.4453	43	white	35	60	0.567993	0.455994	3	0	0	no	null	null	dnr after sadm	5	77	12.099609	130	30	39	357.125	2.799805	0.599976	0.899902	136	7.469727	140	9	1,750	null	1	<2 mo. follow-up	1
3,112	65.98499	1	male	0	9	43	Lung Cancer	Cancer	1	8	under $11k	0	16,239	8,887.7891	7,716.37891	17.5	white	21.5	24	0.60498	0.286987	1	0	0	metastatic	0.5	0.1	dnr after sadm	1	70	null	80	20	34.39844	null	null	null	1.399902	126	null	115	38	350	null	3	<2 mo. follow-up	3
3,113	64.95599	1	male	0	6	77	Lung Cancer	Cancer	2	10	$11-$25k	0	6,889	3,987.8144	3,800.53906	8	white	17.597656	12	0.695923	0.406982	1	0	0	metastatic	0.65	0.25	no dnr	6	54	18.296875	121	10	38.79688	165	2.699707	0.899902	1.399902	146	7.489258	264	23	3,751	0	2	no(M2 and SIP pres)	2
3,114	73.77997	1	female	0	5	166	Colon Cancer	Cancer	1	12	null	9	7,095	5,031.3672	4,623.54688	10	white	23.5	20	0.651978	0.346985	1	0	0	metastatic	0.8	0.7	no dnr	5	57	16	138	40	38.09375	182	2.599609	1.299805	0.899902	139	7.449219	250	24	1,515	null	null	null	2.01709
3,115	48.83197	1	female	0	12	59	Lung Cancer	Cancer	2	12	>$50k	9	19,926	10,830.2578	12,196.3125	21.5	white	30.199219	14	0.373962	0.087997	1	0	0	metastatic	0.5	0.3	no dnr	12	55	10.099609	49	10	38.79688	84.4375	2.899902	1	6.699219	139	7.359375	114	112	2,395	null	1	<2 mo. follow-up	1
3,116	99.198	0	female	0	9	469	CHF	COPD/CHF/Cirrhosis	3	12	under $11k	0	9,626	5,471.4766	5,375.6875	7	white	13.699219	24	0.784912	0.655884	1	0	0	yes	0.8	0.7	dnr after sadm	2	75	37.695313	66	22	36.39844	187.5	3.199707	0.399963	1.599854	140	7.369141	181	29	4,525	1	2	no(M2 and SIP pres)	2
3,117	41.46198	1	male	1	3	3	MOSF w/Malig	ARF/MOSF	2	12	$25-$50k	0	17,453	10,567.6562	7,348.61719	35	white	46.398438	99	0.141998	0.066986	1	0	0	yes	0.05	0.05	dnr after sadm	3	72	10.099609	65	20	35.79688	148.3125	3.399902	0.399963	1.899902	135	7.239258	191	49	1,560	null	null	<2 mo. follow-up	2.099609
3,118	68.90594	1	female	0	14	94	Lung Cancer	Cancer	3	12	$11-$25k	0	26,221	13,905.5938	13,046.2188	13.333328	white	38.796875	35	0.120987	0.004999	1	0	0	metastatic	0.5	0.1	dnr after sadm	2	140	7.599609	114	24	36.59375	355	null	0.699951	21.5	136	7.219727	187	174	625	0	0	null	0
3,119	68.06799	0	female	0	4	466	CHF	COPD/CHF/Cirrhosis	6	null	null	0	6,274	null	null	5	white	22.097656	33	0.827881	0.718994	1	1	0	no	0.8	0.6	no dnr	4	42	15.898438	70	37	39.39844	102.84375	2.299805	1.099854	1.399902	148	7.449219	78	51	4,460	null	null	null	3.650391
3,120	72.00494	0	female	0	26	465	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	9	66,389	43,857.75	35,243.2188	22.75	white	33.5	51	0.547974	0.43396	1	1	0	no	0.9	0.9	no dnr	26	107	14.199219	100	12	38.29688	241	3	5.799805	4.5	144	7.429688	163	39	859	2	2	no(M2 and SIP pres)	2
3,121	69.21796	0	male	0	19	463	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	9	75,486	45,836.7188	37,414	22.333328	white	29.097656	35	0.590942	0.481995	9	0	0	no	0.5	0.5	no dnr	19	51	5.899414	116	10	38.79688	55	null	null	2.299805	131	7.25	253	29	765	0	0	no(M2 and SIP pres)	0
3,122	59.63599	1	male	0	4	52	Cirrhosis	COPD/CHF/Cirrhosis	2	16	$25-$50k	0	5,450	2,994.2324	2,717.44922	17	black	19	31	0.807983	0.688965	1	0	0	no	0.8	0.7	no dnr	4	60	7.899414	80	20	36.09375	null	4	0.599976	0.799927	130	null	412	15	null	0	null	<2 mo. follow-up	0.494751
3,123	86.13794	1	female	0	18	20	Colon Cancer	Cancer	2	null	null	0	15,685	9,282.5547	8,388.80469	5	black	36.5	20	0.287964	0.045998	1	0	0	metastatic	0.2	0.01	dnr after sadm	2	195	18.296875	180	33	38.09375	102.84375	null	null	1.399902	137	7.30957	150	16	3,275	0	null	<2 mo. follow-up	0.494751
3,124	85.00195	0	male	0	21	460	ARF/MOSF w/Sepsis	ARF/MOSF	1	16	>$50k	0	43,153	29,686.2969	24,527.2031	19.333328	white	29.199219	42	0.556885	0.44397	5	0	0	no	0.5	0.5	no dnr	21	55	14.398438	80	42	38.39844	153.3125	null	null	0.799927	141	7.399414	115	14	1,081	null	1	no(M2 and SIP pres)	1
3,125	52.25198	1	female	0	17	173	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	37,267	24,023.6406	21,515.75	18	white	23.699219	41	0.812988	0.75	1	0	0	yes	1	0.5	dnr after sadm	9	127	6.699219	114	16	38.59375	91.25	2.099609	0.199982	0.799927	141	7.439453	112	11	2,780	0	null	no(M2 and SIP pres)	0.494751
3,126	74.81494	1	female	1	8	8	Coma	Coma	3	null	null	0	41,314	29,420.4844	24,548.5156	35	white	31.796875	66	0.342957	0.270996	3	1	1	no	0.2	0.2	dnr after sadm	4	117	7.699219	80	20	36.09375	366.625	3.299805	null	0.799927	139	7.40918	92	14	750	null	null	<2 mo. follow-up	4.53125
3,127	80.99896	1	male	1	7	7	Lung Cancer	Cancer	1	14	$25-$50k	9	10,073	5,477.4531	4,782.07812	13.5	white	18.699219	29	0.590942	0.271973	1	0	0	metastatic	0.9	0.5	dnr after sadm	1	60	13.699219	130	12	39.39844	58	null	0.699951	2.899902	141	7.25	128	30	2,226	null	null	<2 mo. follow-up	2.655273
3,128	69.19397	1	female	0	19	200	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	0	52,004	33,686.25	31,089.0781	24	white	27.398438	36	0.628906	0.525879	4	0	0	yes	0.8	0.5	dnr after sadm	1	57	6.599609	100	25	36.19531	304	3.299805	1.799805	1.099854	142	7.479492	109	14	null	3	null	adl>=4 (>=5 if sur)	2.510742
3,129	73.69495	1	female	1	8	8	Lung Cancer	Cancer	2	12	under $11k	9	25,491	10,699.6172	15,917.5391	15.5	white	17.398438	22	0.643921	0.335999	1	0	0	metastatic	0.2	0.1	dnr after sadm	3	70	11.398438	90	20	36.09375	null	2.199707	1.899902	0.899902	132	null	158	25	null	0	0	<2 mo. follow-up	0
3,130	75.27399	1	male	1	10	10	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	$25-$50k	26	null	null	null	48	white	29.699219	68	0.54895	0.434998	1	1	0	no	0.25	0.25	null	null	63	1.599854	45	32	36.09375	412	2.399902	1.299805	1.799805	135	7.40918	216	41	685	null	0	<2 mo. follow-up	0
3,131	42.60898	1	female	0	97	98	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	0	460,909	null	null	33	white	30.097656	50	0.746948	0.666992	7	0	0	no	0.6	0.6	dnr after sadm	93	97	11.699219	80	25	36.69531	null	2.399902	0.299988	0.799927	132	null	528	13	2,900	null	1	adl>=4 (>=5 if sur)	1
3,132	67.37897	0	male	0	9	453	COPD	COPD/CHF/Cirrhosis	6	11	null	0	14,515	9,983.3281	8,710.15625	13.5	white	21.398438	43	0.837891	0.734985	1	1	0	no	0.9	0.6	no dnr	9	77	14.298828	130	12	38.89844	354	2	null	0.799927	140	7.479492	154	22	3,680	1	0	no(M2 and SIP pres)	0
3,133	82.034	1	female	0	4	28	Colon Cancer	Cancer	1	null	null	0	3,777	2,087.0606	1,781.3291	3	white	20.097656	25	0.730957	0.458984	1	0	0	metastatic	null	null	no dnr	4	110	8.798828	110	14	37.89844	192.5	1.899902	0.599976	6.899414	136	7.429688	164	87	1,490	null	null	<2 mo. follow-up	2.875488
3,134	75.87396	1	male	0	109	218	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	0	269,854	null	null	43.75	white	26.898438	64	0.602905	0.495972	4	1	0	yes	0.25	0.2	no dnr	109	81	6.699219	80	20	36.89844	null	3.399902	4.699219	0.799927	136	null	93	17	null	null	null	SIP>=30	2.406738
3,135	75.69598	0	male	0	26	450	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	under $11k	9	50,793	30,239.1094	26,322.875	18.75	white	27.898438	42	0.623901	0.520996	3	0	0	no	0.9	0.9	no dnr	26	103	17.097656	64	22	38	434.5625	3.399902	3.5	4.099609	153	7.469727	75	137	3,040	1	0	no(M2 and SIP pres)	0
3,136	89.72998	1	female	0	5	100	COPD	COPD/CHF/Cirrhosis	6	14	null	0	5,463	3,171.1406	2,975.10938	7	white	17.097656	23	0.763916	0.625	1	0	0	no	0.2	0	dnr after sadm	1	70	12.099609	60	20	36.5	null	3.199707	null	2.199707	131	null	99	54	1,675	1	null	adl>=4 (>=5 if sur)	1.166748
3,137	70.073	1	female	0	9	154	Colon Cancer	Cancer	2	15	$11-$25k	0	17,889	11,542.8047	10,139.3438	15	white	31.5	21	0.500977	0.179993	1	0	0	metastatic	0.5	0.2	dnr after sadm	2	73	3.699707	60	20	35.59375	null	3.299805	null	1.5	140	null	203	32	1,350	1	0	no(M2 and SIP pres)	0
3,138	66.32196	1	female	1	21	21	Cirrhosis	COPD/CHF/Cirrhosis	6	null	null	0	40,175	23,565.5156	21,078.0938	14	white	22.898438	47	0.55896	0.362976	1	1	0	metastatic	0.75	0.1	dnr after sadm	2	73	6.5	80	25	36.09375	242.84375	3.599609	0.5	2.399902	143	7.539062	50	68	2,100	null	null	<2 mo. follow-up	4.582031
3,139	90.75995	1	male	0	11	22	ARF/MOSF w/Sepsis	ARF/MOSF	3	null	null	0	18,985	12,499.0547	10,377.8281	17.5	white	29.097656	54	0.585938	0.475952	1	1	0	no	0.7	0.5	dnr before sadm	-1	123	null	104	28	36.19531	200	2.399902	0.599976	4.099609	137	7.449219	166	76	1,800	null	null	<2 mo. follow-up	4.538086
3,140	71.13495	0	female	0	4	446	ARF/MOSF w/Sepsis	ARF/MOSF	4	8	under $11k	41	15,780	11,261.8438	9,187.79688	11	white	21.296875	24	0.671997	0.576904	3	0	1	no	0.4	0.3	no dnr	4	77	13.5	60	24	36.09375	145	null	0.599976	0.699951	141	7.359375	144	14	1,700	null	6	adl>=4 (>=5 if sur)	6
3,141	57.92499	0	female	0	9	446	CHF	COPD/CHF/Cirrhosis	3	12	under $11k	0	8,734	5,139.0586	4,937.85938	7.5	hispanic	19.199219	33	0.887939	0.812988	1	1	0	no	0.99	0.99	no dnr	9	65	11.5	106	28	37.79688	null	null	null	1	136	null	130	14	1,150	2	3	SIP>=30	3
3,142	89.47296	1	male	0	13	43	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	>$50k	0	44,299	26,925.4062	22,463.3906	25.5	white	20.398438	24	0.642944	0.542969	12	0	1	yes	0.8	0.7	no dnr	13	83	16	80	20	36.09375	214.8125	3.899902	0.899902	0.699951	142	7.389648	102	20	null	null	7	<2 mo. follow-up	7
3,143	68.17499	1	male	1	11	11	ARF/MOSF w/Sepsis	ARF/MOSF	2	9	under $11k	0	24,260	16,137.75	12,682.9766	25.5	white	31.898438	66	0.576904	0.46698	1	0	1	yes	0.5	0.2	no dnr	11	77	6.5	80	25	36.29688	288	2.899902	null	1	136	7.469727	208	23	null	null	1	<2 mo. follow-up	1
3,144	79.80597	0	female	0	13	443	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	null	0	34,574	null	null	29.5	white	18.597656	42	0.831909	0.774902	1	0	0	no	1	0.9	dnr after sadm	2	107	6.899414	100	26	35.39844	null	4	null	1.099854	139	null	106	19	3,250	null	1	no(M2 and SIP pres)	1
3,145	63.198	1	male	1	7	7	MOSF w/Malig	ARF/MOSF	4	12	null	0	34,958	24,062.5781	20,694.8281	23.5	white	22.199219	61	0.716919	0.630981	2	1	0	yes	0.3	0.5	dnr after sadm	6	119	0.199982	124	38	38.59375	121.65625	2.299805	1.199951	1.399902	151	7.419922	145	27	3,455	2	2	<2 mo. follow-up	2
3,146	81.21796	0	female	0	13	440	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	under $11k	0	30,348	16,742.7344	15,341.9531	28.5	white	16	18	0.85791	0.80896	1	0	0	no	0.6	0.5	dnr before sadm	-1	62	14.398438	180	12	38	197.5	null	null	4.799805	140	7.449219	179	45	540	null	4	SIP>=30	4
3,147	56.556	0	female	0	7	437	COPD	COPD/CHF/Cirrhosis	2	8	under $11k	0	11,227	null	null	6.5	white	19.898438	36	0.897949	0.827881	1	1	0	no	0.9	0.75	no dnr	7	53	20.898438	120	8	32.59375	48	1	null	1.199951	130	7.379883	147	13	419	0	0	null	0
3,148	91.01996	0	female	0	9	438	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	$25-$50k	37	18,010	null	null	14	white	17.296875	26	0.703979	0.61499	1	0	0	no	0.85	0.614	dnr after sadm	1	127	11.199219	80	20	36.09375	null	3.599609	null	3.899902	142	null	124	56	null	null	2	adl>=4 (>=5 if sur)	2
3,149	40.67599	0	female	0	28	437	ARF/MOSF w/Sepsis	ARF/MOSF	0	13	>$50k	0	89,921	67,147.9375	53,362.0938	34.75	white	39.09375	45	0.633911	0.531982	1	0	0	no	0.65	0.65	no dnr	28	38	1	140	32	36.29688	193.3125	null	null	2.599609	146	7.389648	146	82	0	null	0	no(M2 and SIP pres)	0
3,150	81.00195	0	male	0	43	436	ARF/MOSF w/Sepsis	ARF/MOSF	0	10	under $11k	0	79,981	45,042.25	37,953.8125	17.75	white	21.898438	34	0.780884	0.710938	1	0	0	no	0.6	0.55	dnr after sadm	33	71	11.298828	110	22	35.59375	200	3	0.799927	1.799805	136	7.469727	102	45	3,925	0	1	no(M2 and SIP pres)	1
3,151	85.80194	1	male	0	13	31	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	under $11k	26	20,685	12,158.5781	9,281.91406	16.5	white	21.398438	42	0.684937	0.591919	1	0	1	no	0.8	0.7	dnr before sadm	-1	47	12.099609	144	16	38.09375	100	1.799805	0.399963	1.099854	137	7.359375	91	20	2,760	null	6	<2 mo. follow-up	6
3,152	73.24298	1	female	0	11	153	COPD	COPD/CHF/Cirrhosis	2	12	null	0	14,628	7,396.7266	7,355.19922	5	white	20.699219	32	0.813965	0.698975	1	0	0	no	0.8	0.6	dnr before sadm	-1	57	null	120	20	36.19531	null	null	null	null	140	null	null	null	null	3	2	SIP>=30	2
3,153	83.20099	1	male	0	8	35	Lung Cancer	Cancer	3	12	under $11k	41	8,584	4,957.8984	4,076.82812	10.5	white	15	13	0.531982	0.208984	1	1	0	metastatic	0.6	0.4	no dnr	8	67	9.298828	87	16	36.09375	null	null	null	0.699951	132	null	147	14	null	null	7	<2 mo. follow-up	7
3,154	65.34399	1	male	1	25	25	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	0	65,291	null	null	21	white	32.59375	57	0.576904	0.46698	1	1	0	yes	0.5	0	dnr after sadm	24	90	12.898438	100	20	37.19531	290.4375	null	null	0.799927	139	7.449219	126	17	null	0	0	<2 mo. follow-up	0
3,155	70.47998	1	male	0	33	190	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	null	37	124,697	null	null	28.75	white	23	56	0.599976	0.491943	2	0	0	yes	0.2	0.05	no dnr	33	107	4.399414	70	20	36.69531	304.75	2.599609	0.299988	1	143	7.449219	122	14	445	null	null	Coma or Intub	2.585449
3,156	31.17899	1	male	1	17	17	MOSF w/Malig	ARF/MOSF	2	14	$25-$50k	0	120,808	null	null	47	white	34.59375	57	0.493958	0.375977	1	0	0	yes	0.5	0.5	dnr after sadm	12	85	9.599609	60	18	36.5	null	2.399902	0.599976	0.699951	141	null	208	14	3,600	null	0	<2 mo. follow-up	0
3,157	46.55399	0	male	0	11	429	ARF/MOSF w/Sepsis	ARF/MOSF	1	13	$11-$25k	0	41,692	20,516.0469	24,885.3906	19	white	15.199219	32	0.903931	0.869995	2	0	0	yes	0.99	0.99	no dnr	11	73	6.699219	80	20	36.69531	483.3125	null	null	1.199951	139	7.349609	97	30	625	0	0	no(M2 and SIP pres)	0
3,158	78.45898	1	male	0	7	347	ARF/MOSF w/Sepsis	ARF/MOSF	2	3	$11-$25k	0	13,683	9,479.7422	8,309.50781	4	white	21.097656	33	0.726929	0.642944	3	0	0	yes	0.8	0.75	no dnr	7	111	0.099991	130	16	35.59375	145	2	2.699707	3	130	7.259766	116	67	243	0	0	no(M2 and SIP pres)	0
3,159	83.59198	0	female	0	10	428	ARF/MOSF w/Sepsis	ARF/MOSF	2	8	under $11k	0	16,860	9,524.4922	8,219.44531	17.5	white	27.097656	29	0.672974	0.577881	1	1	0	no	0.9	0.8	no dnr	10	71	15.599609	64	8	36.69531	160	2.699707	0.399963	1.199951	141	7.459961	156	22	1,020	1	null	no(M2 and SIP pres)	1.166748
3,160	79.75598	0	male	0	10	428	MOSF w/Malig	ARF/MOSF	2	12	$25-$50k	0	17,840	12,445.2969	11,083.6484	16.5	white	22	29	0.717896	0.631958	1	0	0	yes	0.5	0.3	dnr after sadm	1	38	6.5	120	15	36.69531	419	3.099609	null	1	132	7.449219	92	9	null	0	1	adl>=4 (>=5 if sur)	1
3,161	78.76794	0	male	0	8	428	ARF/MOSF w/Sepsis	ARF/MOSF	4	13	null	9	18,086	12,766.6875	12,071.7656	21.5	white	18.898438	34	0.810913	0.747925	1	1	1	no	0.8	0.7	no dnr	8	97	10.699219	70	25	36.79688	null	null	null	2.799805	141	null	154	46	1,750	null	2	adl>=4 (>=5 if sur)	2
3,162	28.44099	0	male	0	5	426	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	11,832	8,365.3359	7,131.01953	22	null	14.099609	24	0.953979	0.93689	1	0	0	no	1	1	no dnr	5	49	8.398438	53	36	35.79688	169.375	null	null	1.699951	134	7.439453	57	26	3,025	null	null	null	2.216797
3,163	41.69199	1	male	0	4	295	Lung Cancer	Cancer	2	15	$11-$25k	0	16,184	null	null	16	white	1.199951	20	0.925903	0.826904	1	0	0	metastatic	1	0.8	no dnr	4	102	10.599609	70	30	36.89844	121.65625	null	7.299805	1	142	7.459961	91	16	3,955	null	null	no(M2 and SIP pres)	1.597168
3,164	69.76294	0	female	0	7	425	COPD	COPD/CHF/Cirrhosis	2	10	under $11k	0	8,789	4,800.1484	4,513.07812	5	white	19.699219	16	0.848999	0.751953	1	0	0	no	0.7	0.7	no dnr	7	80	4.199219	70	20	36.09375	null	1.699951	3.299805	1.199951	132	null	88	32	null	1	1	no(M2 and SIP pres)	1
3,165	82.14099	1	female	0	7	10	MOSF w/Malig	ARF/MOSF	3	null	null	9	12,928	7,280.9922	6,365.59766	18	white	30.796875	47	0.458984	0.339966	1	0	1	yes	0.7	0.5	dnr after sadm	1	100	13.398438	112	20	36.09375	null	2.199707	null	0.699951	141	null	78	8	null	null	null	<2 mo. follow-up	5.588867
3,166	73.28998	1	female	0	9	163	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	null	9	22,415	14,768.2969	13,390.3438	21.5	white	23.699219	28	0.756958	0.679932	1	0	0	no	0.75	0.65	no dnr	9	80	12.798828	60	28	36.69531	78.32812	2	null	0.799927	148	7.439453	120	30	2,125	0	0	no(M2 and SIP pres)	0
3,167	70.70197	1	female	0	6	123	Lung Cancer	Cancer	1	18	>$50k	0	8,339	4,873	5,015.31641	9	white	15.199219	9	0.72998	0.458984	1	0	0	metastatic	0.6	0.2	no dnr	6	103	15.398438	121	6	37.79688	520	2.5	0.799927	10.099609	147	7.339844	185	67	2,870	0	0	no(M2 and SIP pres)	0
3,168	50.52399	0	female	0	47	421	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	176,139	120,280.312	94,567.375	29	white	25.097656	58	0.797974	0.730957	7	0	0	no	0.85	0.75	no dnr	47	130	19.898438	79	44	37.69531	97.95312	2.5	0.5	3.299805	148	7.449219	185	56	1,160	null	null	null	2.606934
3,169	91.68799	1	male	0	7	18	COPD	COPD/CHF/Cirrhosis	6	12	null	9	9,399	5,090.8633	5,382.42969	7.5	black	21.699219	31	0.543945	0.345947	1	0	1	yes	0.7	0.2	no dnr	7	77	61.296875	80	30	37	null	null	null	1	143	null	435	18	null	null	null	<2 mo. follow-up	7.073242
3,170	54.95398	1	female	0	14	58	Lung Cancer	Cancer	2	9	under $11k	0	15,766	9,523.3125	13,740.3359	4.333332	hispanic	22	36	0.625977	0.312988	1	0	0	metastatic	0.6	0.4	dnr after sadm	1	67	4.299805	112	10	36.19531	330	2.599609	2.799805	1.599854	148	7.339844	100	22	1,155	0	2	<2 mo. follow-up	2
3,171	80.41095	1	female	0	9	182	CHF	COPD/CHF/Cirrhosis	6	null	null	0	10,985	5,983.1719	5,310.14844	8	null	14.199219	34	0.87793	0.796997	1	0	0	no	0.7	0.7	dnr after sadm	1	121	11.199219	81	22	36.5	244	3.299805	0.299988	3.5	135	7.449219	125	37	2,775	null	null	null	3.723633
3,172	82.90198	1	female	1	3	3	Coma	Coma	3	12	under $11k	55	12,558	7,413.4844	6,664.97656	30	white	21	56	0.252991	0.185974	1	0	0	yes	null	null	dnr after sadm	1	123	10.599609	104	24	38.59375	357.125	null	null	1.099854	134	7.459961	79	16	1,121	null	null	<2 mo. follow-up	2.826172
3,173	78.80096	1	female	0	15	180	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	0	23,985	15,362.7188	12,458.1875	16.333328	white	19.398438	30	0.782959	0.712891	1	1	1	yes	0.95	0.9	dnr before sadm	-1	60	23.898438	100	16	37.89844	160	4.099609	2.5	4.599609	137	7.389648	227	62	202	null	7	adl>=4 (>=5 if sur)	7
3,174	94.60095	1	female	0	6	13	CHF	COPD/CHF/Cirrhosis	4	17	>$50k	9	8,027	4,217.5195	3,730.28906	13	white	24.796875	42	0.618896	0.432983	1	0	1	no	0.9	0.6	dnr after sadm	1	66	8.699219	116	16	37.89844	null	4.099609	1	2.799805	133	null	291	39	4,525	null	null	<2 mo. follow-up	6.5625
3,175	47.56998	1	female	1	28	28	MOSF w/Malig	ARF/MOSF	4	17	$25-$50k	0	141,244	null	null	34	white	25.398438	55	0.618896	0.513916	9	1	0	yes	0.5	0.3	no dnr	28	60	21.699219	130	14	38.69531	97	1.5	1.199951	0.599976	137	7.379883	313	10	1,764	null	7	<2 mo. follow-up	7
3,176	55.68799	0	female	0	19	415	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	null	0	73,326	44,157.9062	42,893.875	35.666657	white	12	20	0.934937	0.909912	1	1	0	no	0.9	0.9	no dnr	19	70	6.299805	73	30	35.89844	228	null	0.599976	2.299805	136	7.299805	265	116	null	null	0	no(M2 and SIP pres)	0
3,177	76.66296	0	female	0	18	413	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	0	90,617	51,941.1562	49,604.1562	42	white	28.097656	33	0.550903	0.437988	6	0	0	yes	0.5	0.4	no dnr	18	117	8.398438	90	20	36.09375	null	3.799805	11	0.799927	136	null	89	8	null	null	0	no(M2 and SIP pres)	0
3,178	77.87799	1	male	0	13	44	MOSF w/Malig	ARF/MOSF	1	20	null	41	20,672	13,498.3672	11,308.9297	20.5	white	27.296875	51	0.314941	0.201996	1	0	0	metastatic	0.25	0.05	dnr after sadm	2	57	7.899414	100	30	39.29688	121.65625	1.899902	null	1.799805	140	7.449219	295	43	5,690	null	0	<2 mo. follow-up	0
3,179	68.98297	0	female	0	33	410	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	9	73,746	46,496.7812	42,932.6562	25.5	white	36.898438	74	0.470947	0.35199	1	0	0	no	0.5	0.5	no dnr	33	123	10.599609	102	28	36.19531	null	3.099609	null	5.199219	148	null	155	40	1,255	null	0	no(M2 and SIP pres)	0
3,180	59.66098	0	male	0	4	410	CHF	COPD/CHF/Cirrhosis	4	22	>$50k	0	4,702	2,460.8809	2,220.26953	14	white	16.699219	21	0.878906	0.79895	1	1	0	yes	0.95	0.9	no dnr	4	123	9.898438	70	20	36.09375	368.3125	null	null	0.799927	135	7.209961	181	30	1,550	0	0	no(M2 and SIP pres)	0
3,181	93.09796	1	female	0	9	15	ARF/MOSF w/Sepsis	ARF/MOSF	2	9	under $11k	9	23,038	13,553.7969	12,280.3359	19	white	35.195313	44	0.35199	0.234985	1	1	0	no	0.5	0.4	no dnr	9	48	10.099609	105	24	37.79688	80	3.099609	0.799927	1.199951	132	7.469727	153	20	1,850	null	7	<2 mo. follow-up	7
3,182	84.79395	0	female	0	5	408	CHF	COPD/CHF/Cirrhosis	2	12	under $11k	0	5,262	null	null	8	white	19.898438	21	0.795898	0.670898	1	0	0	no	1	0.9	no dnr	5	75	5.699219	96	24	36.29688	244	3.599609	0.699951	0.799927	129	7.389648	139	31	3,125	null	null	null	2.417969
3,183	49.10599	1	male	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	0	58,753	null	null	32	white	31.898438	52	0.594971	0.487	13	0	0	yes	0.65	0.3	dnr after sadm	7	97	7	78	24	36.09375	null	2.299805	2.399902	0.699951	135	null	82	15	960	null	null	<2 mo. follow-up	2.718262
3,184	50.92099	0	female	0	6	405	ARF/MOSF w/Sepsis	ARF/MOSF	5	11	under $11k	0	20,417	null	null	16	white	22.796875	37	0.838989	0.783936	4	0	0	no	null	null	no dnr	6	73	12.298828	143	30	38.29688	528.25	2.599609	1.199951	0.799927	132	7.349609	211	24	627	null	2	SIP>=30	2
3,185	88.82996	1	female	0	9	60	ARF/MOSF w/Sepsis	ARF/MOSF	4	8	under $11k	0	14,288	8,781.875	7,294.04688	15	white	31.097656	36	0.545898	0.432983	1	0	0	no	0.65	0.5	dnr after sadm	1	107	8.298828	124	24	36.29688	330	1.5	0.899902	0.799927	147	7.429688	104	12	4,650	null	4	null	4
3,186	63.37598	0	female	0	17	400	COPD	COPD/CHF/Cirrhosis	5	10	null	0	27,526	null	null	14	other	17.199219	31	0.895996	0.825928	1	1	0	no	0.9	0.7	no dnr	17	55	19.199219	70	28	35.59375	370.3125	3.099609	1.199951	2.5	146	7.519531	251	67	1,560	0	1	no(M2 and SIP pres)	1
3,187	47.20099	0	male	0	8	399	MOSF w/Malig	ARF/MOSF	2	18	>$50k	0	19,269	14,394.6953	12,077.0781	17.5	white	33.09375	41	0.505981	0.388977	1	0	0	yes	0.99	0.99	no dnr	8	57	6.099609	70	25	36.09375	533.25	null	null	0.699951	141	7.40918	108	5	2,780	0	0	no(M2 and SIP pres)	0
3,188	31.72899	0	female	0	17	397	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	>$50k	0	46,277	null	null	20.666656	black	20.699219	26	0.917969	0.887939	1	0	0	no	0.95	0.85	no dnr	17	130	6.899414	80	20	37	null	null	null	2.699707	144	null	79	36	1,400	null	null	no(M2 and SIP pres)	1.774414
3,189	51.31299	0	female	0	11	397	Cirrhosis	COPD/CHF/Cirrhosis	3	null	null	0	18,757	null	null	13.5	null	19.296875	21	0.842896	0.741943	1	0	0	no	0.8	0.7	no dnr	11	77	11.798828	80	20	35.89844	null	null	null	1.699951	145	null	94	16	800	null	null	null	2.953613
3,190	77.69995	0	male	0	10	396	CHF	COPD/CHF/Cirrhosis	5	13	$11-$25k	0	13,155	7,146.6094	6,858.62891	9.5	white	18.097656	38	0.806885	0.687988	1	0	0	yes	null	null	no dnr	10	53	4.799805	77	40	35.79688	120	1.799805	0.5	1	135	7.279297	115	24	null	0	0	no(M2 and SIP pres)	0
3,191	86.07794	0	female	0	8	395	COPD	COPD/CHF/Cirrhosis	2	8	null	0	19,059	null	null	15	white	24.796875	32	0.640991	0.459961	1	0	0	no	0.75	0.7	no dnr	8	79	13	58	44	38.09375	285.6875	2.299805	0.5	1.199951	145	7.399414	176	48	1,540	0	0	no(M2 and SIP pres)	0
3,192	82.96198	0	female	0	5	393	CHF	COPD/CHF/Cirrhosis	2	9	under $11k	0	5,468	3,089.1016	2,990.38867	11	white	16.597656	25	0.845947	0.746948	1	0	0	no	0.95	0.9	no dnr	5	74	8.298828	72	40	34.79688	null	1.899902	3.5	0.899902	138	null	299	35	1,505	0	null	no(M2 and SIP pres)	0.494751
3,193	85.90295	0	female	0	6	392	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	$11-$25k	0	8,641	5,966.6211	4,774.98828	18	white	16.796875	35	0.836914	0.780884	1	1	0	no	0.8	0.6	no dnr	6	103	15.699219	58	16	38.19531	436	2.699707	0.5	0.899902	144	7.459961	185	20	1,510	null	7	no(M2 and SIP pres)	7
3,194	60.85999	0	male	0	7	393	CHF	COPD/CHF/Cirrhosis	5	12	under $11k	9	8,193	4,558.7617	4,620.15625	5.5	white	17.5	15	0.850952	0.754883	1	0	0	yes	0.8	0.4	no dnr	7	120	5.199219	90	25	36.09375	208	null	null	1.099854	132	7.339844	537	31	null	1	null	no(M2 and SIP pres)	1.166748
3,195	46.71899	0	male	0	12	391	MOSF w/Malig	ARF/MOSF	1	14	$25-$50k	0	31,701	21,135.6094	17,827.7969	29	white	22.699219	31	0.745972	0.665894	1	0	0	yes	0.9	0.85	no dnr	12	67	15.199219	61	12	38	543.25	3.099609	0.699951	1.099854	138	7.259766	111	13	750	0	0	no(M2 and SIP pres)	0
3,196	68.01398	1	male	0	5	68	Lung Cancer	Cancer	2	9	null	0	5,924	3,249.1504	3,604.47852	10	black	16	9	0.720947	0.444946	1	0	0	metastatic	0.75	0.2	dnr after sadm	4	49	12.5	110	14	39.29688	85	null	4.299805	0.799927	142	7.349609	86	12	4,865	2	null	null	1.838867
3,197	80.05499	1	male	1	10	10	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	$25-$50k	0	75,188	36,809.5312	36,185.5938	48	white	38	54	0.381958	0.263977	2	0	0	no	0.5	0.3	no dnr	10	101	14.599609	110	23	38.89844	230	2.5	1.899902	1.099854	131	7.519531	123	29	1,450	null	0	<2 mo. follow-up	0
3,198	75.33496	1	male	0	4	101	Colon Cancer	Cancer	1	20	$25-$50k	0	5,624	3,108.2344	1,921.0791	6	white	13.298828	11	0.844971	0.658936	1	0	0	metastatic	0.8	0.5	no dnr	4	63	7.899414	100	25	38.69531	143.3125	null	0.799927	1.399902	143	7.419922	161	33	920	0	null	no(M2 and SIP pres)	0.494751
3,199	74.15698	1	male	0	8	101	Lung Cancer	Cancer	4	12	$25-$50k	0	11,663	6,169.6328	5,141.63672	9.5	white	20.199219	25	0.612915	0.297974	1	0	0	metastatic	0.99	0.9	no dnr	8	100	13.298828	120	25	36.5	400	3.799805	null	1.299805	142	7.419922	184	20	800	0	0	adl>=4 (>=5 if sur)	0
3,200	65.52795	0	male	0	14	388	ARF/MOSF w/Sepsis	ARF/MOSF	2	null	$11-$25k	41	30,687	20,530.9375	16,261.0625	11	white	29.796875	24	0.536987	0.421997	1	0	0	no	0.5	0.4	dnr after sadm	1	83	10.599609	80	20	37.09375	253.3125	null	null	1	147	7.379883	99	25	null	2	1	no(M2 and SIP pres)	1

Subsets and Splits

No community queries yet

The top public SQL queries from the community will appear here once available.